Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gender and gallstone disease.

Gottfried Novacek1

  • 1Department of Internal Medicine IV, Division of Gastroenterology and Hepatology, Medical University of Vienna, Vienna, Austria. gottfried.novacek@meduniwien.ac.at

Wiener Medizinische Wochenschrift (1946)
|November 15, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Stoma formation and associated risk factors in patients with Crohn's disease in an Austrian tertiary referral hospital: a retrospective explorative study of long-term follow-up.

Crohn's & colitis 360·2026
Same author

Treatment patterns of eosinophilic esophagitis in the biologic era-a real-world analysis.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2026
Same author

Determination of correlation of clearance with clinical outcomes for inflammatory bowel disease.

World journal of gastroenterology·2026
Same author

Post-induction serum vedolizumab levels are not associated with better maintenance outcomes in patients with Crohn's disease.

Zeitschrift fur Gastroenterologie·2026
Same author

Long-Term Outcome of Ciclosporin and Infliximab as Rescue Therapy in Steroid-Refractory Acute Severe Ulcerative Colitis.

Inflammatory intestinal diseases·2025
Same author

No increase of biopsy rates despite high rates of probable eosinophilic esophagitis in patients with esophageal food impaction.

Wiener klinische Wochenschrift·2025

Female sex hormones, particularly estrogen, significantly increase the risk of cholesterol gallstone formation. This risk is elevated during pregnancy and with hormone therapies, though lower estrogen doses may mitigate this effect.

Area of Science:

  • Gastroenterology
  • Endocrinology
  • Epidemiology

Background:

  • Gallstone disease is a prevalent global health issue, with cholesterol gallstones forming the majority in Western populations.
  • Female gender and pregnancy are identified as significant risk factors for gallstone formation, with higher incidence rates observed in women of childbearing age.

Purpose of the Study:

  • To investigate the role of female sex hormones as risk factors for gallstone disease.
  • To elucidate the mechanisms by which estrogen influences cholesterol gallstone formation.

Main Methods:

  • Review of epidemiological data on gallstone prevalence in relation to gender and reproductive status.
  • Analysis of the physiological effects of estrogen on biliary cholesterol secretion and bile composition.

Related Experiment Videos

Main Results:

  • Gallstone rates are two to three times higher in women than men, particularly during childbearing years.
  • Estrogen increases biliary cholesterol secretion, leading to bile supersaturation and promoting gallstone formation.
  • Hormone replacement therapy and oral contraceptives have been linked to increased gallstone risk, with effects potentially dose-dependent.

Conclusions:

  • Female sex hormones, especially estrogen, are key contributors to gallstone disease pathogenesis.
  • Pregnancy and exogenous hormone therapies necessitate consideration of increased gallstone risk.
  • Lower-dose estrogen formulations in oral contraceptives may present a reduced risk for gallstone formation.